RhumbLine Advisers’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.54M | Buy |
|
|||||
|
2025
Q2 | $1.12M | Buy |
|
|||||
|
2025
Q1 | $781K | Buy |
|
|||||
|
2024
Q4 | $980K | Buy |
|
|||||
|
2024
Q3 | $1.35M | Sell |
|
|||||
|
2024
Q2 | $1.1M | Buy |
|
|||||
|
2024
Q1 | $801K | Buy |
|
|||||
|
2023
Q4 | $682K | Buy |
|
|||||
|
2023
Q3 | $1.11M | Buy |
|
|||||
|
2023
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q1 | $1.01M | Buy |
|
|||||
|
2022
Q4 | $1.07M | Buy |
|
|||||
|
2022
Q3 | $1.32M | Buy |
|
|||||
|
2022
Q2 | $574K | Buy |
|
|||||
|
2022
Q1 | $306K | Buy |
|
|||||
|
2021
Q4 | $333K | Sell |
|
|||||
|
2021
Q3 | $333K | Buy |
|
|||||
|
2021
Q2 | $310K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $85K | Buy |
|